1 rich Libsyn https://www.libsyn.com 90 600 Adjuvant Durvalumab and the Future of Early-Stage NSCLC Guest Dr. Glenwood Goss discuss JCO article, &quot;Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer&quot; and the implications of minimal residual disease, &amp;nbsp;results regarding the efficacy of immunotherapy in the adjuvant setting, and the evolving strategies for patient care in lung cancer treatment. LINK TO FULL TRANSCRIPT Journal of Clinical Oncology (JCO) Podcast http://sites.libsyn.com/58526 <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/41266065/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/00457c/" height="90" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/item/41266065